Orthopaedic Summit 2021 Conference: Dr. Isador Lieberman presents the benefits of ready-to-use for the US market
16 Dezember 2021 - 8:35AM
Orthopaedic Summit 2021 Conference: Dr. Isador Lieberman presents
the benefits of ready-to-use for the US market
Orthopaedic Summit 2021 Conference:
Dr. Isador Lieberman presents the benefits of ready-to-use for the
US market
|
|
|
|
Eragny-sur-Oise,
Fleurieux-sur-l’Arbresle, France, December 10th, 2021 17h45 CET
– Safe (FR0013467123 – ALSAF), a company
specializing in the design, manufacturing and marketing of
single-use technologies for spinal surgeries, delivering the safest
treatment for spinal fractures urgently treated, announces the
presentation of the benefits of Safe Orthopaedics' ready-to-use
technologies at the Orthopaedic Summit 2021 in Las Vegas, USA.
Safe Orthopaedics has launched the distribution
of its technologies in the United States in early 2021, where a
sales manager has been recruited. Safe Orthopaedics relies on a few
strategic centers to demonstrate the medico-economic benefits of
its technologies and works closely with Dr. Isador Lieberman.
Safe Orthopaedics was an exhibitor at the
Orthopaedic Summit 2021 in Las Vegas held December 11-15, 2021. Dr.
Isador Lieberman presented the medico-economic benefits of the
off-the-shelf technologies, testified on the effectiveness of Safe
Orthopaedics' technologies and reminded of the economic stakes in
patient management.
Dr. Isador Liebermann, a spine surgeon
at the Texas Back Institute, comments, "Having worked with
the Safe Orthopaedics team for many years, I was delighted to see
them support this year's OSET meeting in Las Vegas (Orthopaedic
Summit of Emerging Technologies, https://orthosummit.com) and take
advantage of one of our signature sessions. As co-chair of
the OSET spine section, we are always looking for innovative
technologies that improve patient outcomes that we can share with
our colleagues. The time has come for surgeons to realize and
address the economic and ecological issues associated with the
delivery of surgical care. The Safe Orthopaedics team shares
this philosophy and provides surgeons with the tools to do so. The
concept of a ready-to-use instrument and implant with SORA
technology has already been shown to push the boundaries of
efficiency and safety. I look forward to seeing it integrated
into my own operating room."
Pierre Dumouchel, Safe Group's Chairman
and CEO, concluded, "We thank Dr. Lieberman for his
support since our commercial launch in the United States and at the
Orthopaedic Summit 2021. We are working closely together on the
launch of our technologies already approved in the U.S. and on
future ones, such as SORA and others, to come in 2022. The
estimated $5 billion U.S. market is key to our growth. We are
aiming for rapid growth similar to that experienced in France, the
UK and Germany.”
About Safe GroupSafe Group is a
French medical technology group that brings together Safe
Orthopaedics, a pioneer in ready-to-use technologies for spine
pathologies, and Safe Medical (formerly LCI Medical), a medical
device subcontractor for orthopedic surgery. The group employs
approximately 150 people.
Safe Orthopaedics develops and manufactures kits
combining sterile implants and single-use instruments, available at
any time to the surgeon. These technologies are part of a minimally
invasive approach aimed at reducing the risks of contamination and
infection, in the interest of the patient and with a positive
impact on hospitalization times and costs. Protected by 18
patent families, SteriSpineTM kits are CE marked and FDA approved.
Safe Orthopaedics is headquartered in the Paris region (95610
Eragny-sur-Oise) and has subsidiaries in the United Kingdom,
Germany, the United States and the Lyon region
(Fleurieux-sur-l'Arbresle).
For more information:
www.safeorthopaedics.com
Safe Medical produces implantable medical
devices and ready-to-use instruments. It has an innovation center
and two production sites in France (Fleurieux-sur-l'Arbresle,
69210) and in Tunisia, offering numerous industrial services:
design, industrialization, machining, finishing and sterile
packaging. Supported by the French stimulus plan in 2020, the
company invests in additive printing and will be operational in
2022 on this new technology.
For more information: www.safemedical.fr
Contacts
Safe
Group
François-Henri Reynaud
Chief Financial and Administrative Officer
Tél. : +33 (0)1 34 21 50
00
investors@safeorthopaedics.com
Press RelationsUlysse
CommunicationPierre-Louis Germain / +33 (0)6 64 79
97 51 / plgermain@ulysse-communication.com
Bruno Arabian / +33 (0)6 87 88 47 26 /
barabian@ulysse-communication.com
SAFE (EU:ALSAF)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
SAFE (EU:ALSAF)
Historical Stock Chart
Von Jul 2023 bis Jul 2024